SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

StarkNet is a permissionless decentralized Layer 2 (L2) validity rollup, built to allow Ethereum to scale via cryptographic protocols called STARKs, without compromising Ethereum’s core principles of decentralization, transparency, inclusivity and security. The StarkNet Token is needed to operate the ecosystem, maintain and secure it, decide on its values and strategic goals, and direct its evolution. This token will be required for (i) governance, (ii) payment of transaction fees on StarkNet, and (iii) participation in StarkNet’s consensus mechanism.

Starknet

Starknet is actively trending amidst strong ecosystem growth, driven by a surge in Total Value Locked (TVL), increasing stablecoin supply, and significant community engagement with over a billion STRK tokens staked. The platform is gaining considerable attention for its strategic positioning as a leading execution layer for Bitcoin, offering enhanced utility and yield-bearing opportunities. This momentum is further bolstered by its superior ZK-STARK technology, which positions Starknet as a scalable, quantum-resistant, and privacy-centric solution within the broader decentralized finance landscape.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending with high anticipation for its upcoming earnings report, where the community expects strong guidance and updates on critical hyperscaler contracts to validate its AI infrastructure growth story. Positive developments regarding local government approvals for new data center projects are further fueling discussions, as investors eye the potential for a substantial short squeeze and a re-rating of the stock. The focus remains on the company's transition to high-performance computing leases and its expanding role in addressing the AI power bottleneck.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is trending due to a significant financial restructuring that has substantially reduced its debt and bolstered its balance sheet. The strategic acquisition of Ask Sage and high anticipation for major government contracts in AI-driven defense and intelligence are fueling strong community optimism. Discussions frequently compare BBAI to Palantir, with many expecting significant upside as it solidifies its role in secure AI applications.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk is experiencing significant market attention following commentary from NVIDIA's CEO regarding severe memory bottlenecks impacting AI infrastructure. This has ignited a passionate debate within the community, with many celebrating the stock's parabolic ascent as an "AI memory supercycle," while others express strong skepticism, labeling it an overvalued "speculative bubble." The rapid surge reflects the intense focus on how AI-driven data demand is impacting the broader memory and storage sector.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is seeing significant discussion as MSCI announced it will not exclude digital asset treasury companies from its global indexes for the upcoming February 2026 review, alleviating a major overhang. This decision is fueling bullish sentiment, with many anticipating a substantial short squeeze and a path to higher valuations, while bears remain focused on dilution risks and the stock's correlation to Bitcoin's sustained strength.

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Regencell Bioscience Holdings Ltd

Regencell Bioscience Holdings Ltd (RGC) is trending due to significant short squeeze potential, as evidenced by a severe shortage of shortable shares and soaring borrow rates. The community is actively discussing the stock's low float and comparing it to past parabolic moves and meme stock events, anticipating a substantial upward price swing.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is experiencing heightened conversation following its recent announcement regarding site selection for a pioneering fusion power plant, driving significant investor speculation. This development, alongside ongoing discussions surrounding former President Trump's geopolitical actions concerning Venezuela's oil and potential acquisition of Greenland, fuels a highly polarized community debate. Many view the fusion energy venture as a massive growth opportunity, while critics highlight the highly speculative nature of these initiatives and continued high short interest in the stock.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is a major talking point amid mixed sentiment, with technical analysts highlighting a significant losing streak and an oversold RSI signaling potential for a rebound from key support levels. The community is actively debating its recent underperformance relative to the broader market and perceived lack of visible AI innovation, contrasting with bullish calls citing strong underlying sales and heavy call option activity ahead of upcoming earnings. Despite some analyst downgrades, many traders see current price action as an opportunity for accumulation, anticipating a bounce.

Ventyx Biosciences, Inc. engages in developing novel small molecule therapeutics for the treatment of autoimmune diseases. Its clinical stage pipeline includes VTX958, a Phase 1 allosteric TYK2 inhibitor for the treatment of a broad range of autoimmune diseases, VTX002, a Phase 2-ready S1P1 receptor modulator for the treatment of ulcerative colitis, and VTX2735, a Phase 1-ready peripheral inhibitor of the NLRP3 inflammasome, which is a mediator of multiple inflammatory conditions. The company was founded by Raju S. Mohan on November 21, 2018 and is headquartered in San Diego, CA.

Ventyx Biosciences Inc

Ventyx Biosciences (VTYX) is trending amidst reports that Eli Lilly ($LLY) is in advanced talks to acquire the company for over $1 billion, sparking widespread discussion about its valuation. The community is actively debating whether the rumored price adequately reflects Ventyx's promising NLRP3 inhibitor pipeline, which is seen as strategically valuable for addressing various inflammatory and metabolic conditions. This potential deal highlights the intense M&A activity in the biopharma sector for assets that could complement existing therapies and unlock new treatment paradigms.

Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies. The company was founded on January 29, 2021 and is headquartered in San Francisco, CA.

Alumis Inc.

Alumis Inc. is currently trending due to exceptionally positive Phase 3 clinical trial results for its oral TYK2 inhibitor, envudeucitinib, for plaque psoriasis, which met all primary and secondary endpoints with strong efficacy and a favorable safety profile. The community is actively discussing the drug's "best-in-class" potential and competitive profile, with several analysts raising price targets. Despite the strong clinical news, there's also notable conversation and some caution regarding a recently proposed public offering.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


sin88vntn

Sin88vn To